Nilo Therapeutics
PrivateLast Round
Series A
Oct 8, 2025
Total Funding Raised
$101M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nilo Therapeutics is a biotechnology company that develops a class of medicines that harness neural circuits to restore immune homeostasis in disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nilo Therapeutics Comparables
Compare Nilo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GSK plc | 74% | |
| Kallyope | 70% | |
| Nimbus Therapeutics | 67% |
Nilo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 8, 2025 |
Key People
Founding team and executive leadership
Nilo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series A |
| DCVC Bio | Series A |
| Gates Family Foundation | Series A |
| Lux Capital | Series A |
| Gates Foundation | Series A |
| Bill & Melinda Gates Foundation | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2025
$101M Series A round completed.
- Oct 8, 2025
Kim Seth, Ph.D. appointed as Chief Executive Officer and Board director.
Nilo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nilo Therapeutics's valuation, stock price, and market status.
Is Nilo Therapeutics a public or private company?
Nilo Therapeutics is a private company.
What is the current stock price of Nilo Therapeutics?
Nilo Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Nilo Therapeutics worth (valuation)?
Valuation information for Nilo Therapeutics is not publicly available.
Can I buy Nilo Therapeutics stock?
Nilo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nilo Therapeutics's last funding round?
Nilo Therapeutics's most recent funding round was Series A on October 8, 2025.
Who are the main investors in Nilo Therapeutics?
Key investors in Nilo Therapeutics include The Column Group, DCVC Bio, Lux Capital.
Will Nilo Therapeutics IPO soon?
No public IPO plans have been announced for Nilo Therapeutics.
How can I track Nilo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nilo Therapeutics's secondary market activity and sign up for updates.